Abbott Laboratories (ABT) has agreed to acquire Alere Inc. (ALR).The deal was first announced in early 2016 but Abbott had accused Alere of misleading them and lawsuits were filed. Abbott originally offered $56 per share but the new agreement has reduced the price to $51 per share and is expected to close prior to the end of the year. All lawsuits have been dismissed.
Abbott Laboratories also recently acquired St. Jude Medical, a leading provider of Medical devices.
Abbott is engaged in the manufacture of large areas of Pharmaceutical Products including Nutrition, Heart Health, Diagnostics, Diabetes Care and Medical Devices. Their product list includes popular brands for consumers as well as Healthcare Professionals.
Some analyst are saying Abbott has the potential for a 20% upside in stock price.